Article: Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase NAD+ Levels: Preclinical Findings

PrevNext
Metabolic Health Preclinical

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase NAD+ Levels: Preclinical Findings

Synopsis

Eukaryotic cells use multiple molecules as NAD+ precursors, but how they work together is unclear. This study identified dihydronicotinic acid riboside (NARH) as a new NAD+ precursor in liver cells. Unlike other precursors, NARH combined with nicotinamide riboside (NR) greatly increased NAD+ levels in cells and mice, due to chemical conversion to dihydronicotinamide riboside (NRH). This is the first report showing NARH acts as a NAD+ precursor and that NAD+ precursors can interact to enhance each other's effects.

Journal

Nutrients

Share

Read more

Preclinical

Nicotinamide Riboside May Help Reactivate Early Human Embryos in IVF: Preclinical Findings

Synopsis During in vitro fertilization (IVF), nearly 60% of human embryos stop developing early—between the 3- and 8-cell stages—making it a major challenge for successful pregnancies. This study ...

Read more
Cellular Health

Nicotinamide Riboside Supports Long-Term Function of Blood Stem Cells: Preclinical Findings

Synopsis Hematopoietic stem cells (HSCs), which produce blood cells, adjust their metabolism depending on whether they are resting or dividing. When HSCs are in maintenance mode, they break down a...

Read more